Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Grindlay

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
The Journal of General Virology|July 1, 1996
Vaccination of cattle with bovine papillomavirus type 4 L2 elicits the production of virus-neutralizing antibodiesJ M Gaukroger, L M Chandrachud, B W O'Neil, et al.
The Journal of General Virology|June 1, 1993
Prophylactic and therapeutic vaccination against a mucosal papillomavirusM S Campo, G J Grindlay, B W O'Neil, et al.
Molecular Carcinogenesis|January 1, 1991
The B subgroup bovine papillomaviruses lack an identifiable E6 open reading frameM E Jackson, W D Pennie, R E McCaffery, et al.
Virology|April 1, 1994
Humoral immune response to the E7 protein of bovine papillomavirus type 4 and identification of B-cell epitopesL M Chandrachud, B W O'Neil, W F Jarrett, et al.
Virology|January 10, 1995
T cell responses to BPV-4 E7 during infection and mapping of T cell epitopesG M McGarvie, G J Grindlay, L M Chandrachud, et al.
Nucleic Acids Research|August 11, 1980
Repetitive DNA sequences near three human beta-type globin genesL W Coggins, G J Grindlay, J K Vass, et al.
Progress in Clinical and Biological Research|January 1, 1985
Distant sequences which regulate globin genesJ Paul, M Allan, S Gilmour, et al.
Virology|August 1, 1995
Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus-4L M Chandrachud, G J Grindlay, G M McGarvie, et al.
BMJ Open|March 27, 2021
Common hand and wrist conditions: creation of UK research priorities defined by a James Lind Alliance Priority Setting PartnershipAlexia Karantana, Tim Davis, Donna Kennedy, et al.
Virology|September 1, 1991
Studies on vaccination against papillomaviruses: prophylactic and therapeutic vaccination with recombinant structural proteinsW F Jarrett, K T Smith, B W O'Neil, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The Journal of General Virology|July 1, 1996
Vaccination of cattle with bovine papillomavirus type 4 L2 elicits the production of virus-neutralizing antibodiesJ M Gaukroger, L M Chandrachud, B W O'Neil, et al.
The Journal of General Virology|June 1, 1993
Prophylactic and therapeutic vaccination against a mucosal papillomavirusM S Campo, G J Grindlay, B W O'Neil, et al.
Molecular Carcinogenesis|January 1, 1991
The B subgroup bovine papillomaviruses lack an identifiable E6 open reading frameM E Jackson, W D Pennie, R E McCaffery, et al.
Virology|April 1, 1994
Humoral immune response to the E7 protein of bovine papillomavirus type 4 and identification of B-cell epitopesL M Chandrachud, B W O'Neil, W F Jarrett, et al.
Virology|January 10, 1995
T cell responses to BPV-4 E7 during infection and mapping of T cell epitopesG M McGarvie, G J Grindlay, L M Chandrachud, et al.
Nucleic Acids Research|August 11, 1980
Repetitive DNA sequences near three human beta-type globin genesL W Coggins, G J Grindlay, J K Vass, et al.
Progress in Clinical and Biological Research|January 1, 1985
Distant sequences which regulate globin genesJ Paul, M Allan, S Gilmour, et al.
Virology|August 1, 1995
Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus-4L M Chandrachud, G J Grindlay, G M McGarvie, et al.
BMJ Open|March 27, 2021
Common hand and wrist conditions: creation of UK research priorities defined by a James Lind Alliance Priority Setting PartnershipAlexia Karantana, Tim Davis, Donna Kennedy, et al.
Virology|September 1, 1991
Studies on vaccination against papillomaviruses: prophylactic and therapeutic vaccination with recombinant structural proteinsW F Jarrett, K T Smith, B W O'Neil, et al.
Pageof 4